Show simple item record

FieldValueLanguage
dc.contributor.authorErdrich, Sharon
dc.date.accessioned2025-04-14T02:26:39Z
dc.date.available2025-04-14T02:26:39Z
dc.date.issued2025en_AU
dc.identifier.urihttps://hdl.handle.net/2123/33816
dc.descriptionIncludes publication
dc.description.abstractFibromyalgia is a common idiopathic chronic pain condition that is almost ten times more common than rheumatoid arthritis. However, it is one of the least researched rheumatological conditions. The high co-prevalence of digestive problems that are now categorised as disorders of gut-brain interaction (DGBI) adds to the difficulties people with fibromyalgia face having their complaints taken seriously. A paucity of effective treatments poses additional challenges for those with the condition. Research linking the microbiome of the human gut with a range of pathologies – gastrointestinal and extra-gastrointestinal – is accumulating. To date, there are few studies examining associations between the gut microbiome and fibromyalgia. Therefore, the primary aim of this thesis was to investigate the relationships between the common symptoms of fibromyalgia and the digestive disorders collectively called DGBI, and the microbiome of the gastrointestinal tract. In addition to comparing clinical features evident in the group of women with fibromyalgia (n = 113) with age-matched controls (n = 55), relationships between these features were examined. Novel findings were significantly poorer oral health scores in the fibromyalgia group, which were associated with DGBI, which were also associated with more severe presentation of fibromyalgia symptoms. Significant differences were found between oral microbiota and measures of pain, and a range of clinical characteristics in women with fibromyalgia, particularly DGBI. Differences in faecal microbiota were associated with a range of clinical measures, including cognition, sleep, and DGBI. New insights are provided in linking the complexity of fibromyalgia with oral health, which has been overlooked in this population until now. Together, the results add to the current knowledge base, invite a new hypothesis and provide a basis for further exploration of this enigmatic condition.en_AU
dc.language.isoenen_AU
dc.subjectfibromyalgiaen_AU
dc.subjectDGBIen_AU
dc.subjectmicrobiomeen_AU
dc.subjectoral healthen_AU
dc.subjectIBSen_AU
dc.subjectdigestionen_AU
dc.titleThe FIDGIT Study: an investigation into the relationships between the symptoms of Fibromyalgia, Digestive function, and the microbiome of the Gastrointestinal Tracten_AU
dc.typeThesis
dc.type.thesisDoctor of Philosophyen_AU
dc.rights.otherThe author retains copyright of this thesis. It may only be used for the purposes of research and study. It must not be used for any other purposes and may not be transmitted or shared with others without prior permission.en_AU
usyd.facultySeS faculties schools::Faculty of Medicine and Health::The University of Sydney School of Pharmacyen_AU
usyd.degreeDoctor of Philosophy Ph.D.en_AU
usyd.awardinginstThe University of Sydneyen_AU
usyd.advisorHarnett, Joanna
usyd.include.pubYesen_AU


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.